{"id":17833,"date":"2020-02-05T09:37:02","date_gmt":"2020-02-05T08:37:02","guid":{"rendered":"https:\/\/www.satt.fr\/satt-up-lactualite-des-start-up-accompagnees-par-les-satt-14-janvier-2020\/"},"modified":"2020-02-05T14:08:49","modified_gmt":"2020-02-05T13:08:49","slug":"satt-up-janvier-2020","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/","title":{"rendered":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020"},"content":{"rendered":"<div id=\"pl-17833\"  class=\"panel-layout\" ><div id=\"pg-17833-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-17833-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child panel-last-child\" data-index=\"0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong>Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 418 start-up Deep Tech #SATTUP !<\/strong><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><div id=\"pg-17833-1\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-17833-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-1-0-0\" class=\"so-panel widget widget_text panel-first-child panel-last-child\" data-index=\"1\" >\t\t\t<div class=\"textwidget\"><p><strong>NewClin, une clinique virtuelle pour accompagner le grand public dans une d\u00e9marche de sant\u00e9 personnalis\u00e9e.<\/strong>\u00a0<em>(PULSALYS)<\/em><\/p>\n<p>Incub\u00e9e par PULSALYS, la startup NewClin d\u00e9veloppe une plateforme digitale gratuite d\u2019e-sant\u00e9 bas\u00e9e sur l\u2019intelligence artificielle et le big data. Face aux difficult\u00e9s d\u2019acc\u00e8s aux services de sant\u00e9, NewClin a pour ambition d\u2019apporter des r\u00e9ponses rapides et personnalis\u00e9es \u00e0 chaque usager. Cette \u00ab clinique virtuelle \u00bb qui pourrait \u00eatre d\u00e9ploy\u00e9e en France \u00e0 partir de fin 2020, a pour ambition de devenir un espace personnel o\u00f9 chaque utilisateur pourra acc\u00e9der au parcours de sant\u00e9 auquel il aspire et a droit.<\/p>\n<p><a href=\"https:\/\/www.newclin.com\/\">www.newclin.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<\/div>\n\t\t<\/div><\/div><div id=\"pgc-17833-1-1\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-1-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"2\" ><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"43\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Newclin-Carre-150x43.png\" class=\"image wp-image-17811  attachment-thumbnail size-thumbnail\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Newclin-Carre-150x43.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Newclin-Carre-300x86.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Newclin-Carre-200x57.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Newclin-Carre.png 375w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/div><\/div><\/div><div id=\"pg-17833-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-17833-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-2-0-0\" class=\"so-panel widget widget_text panel-first-child panel-last-child\" data-index=\"3\" >\t\t\t<div class=\"textwidget\"><p><strong>Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies and Payloads for Preparation of New Classes of Biologics.<\/strong>\u00a0<em>(Conectus)<\/em><\/p>\n<p>Syndivia, a biotechnology company focused on the development of new therapeutic modalities for solid cancers based on a specific targeting of the tumour microenvironment and anatomical hallmarks, announced today that it has been granted an exclusive, worldwide license by SATT Conectus for a technology (DARx) that opens access to a wide range of previously inaccessible biologics formats, such as antibody\u2013drug, antibody\u2013oligonucleotide, and antibody\u2013interleukin conjugates with a defined degree of conjugation of 1. This minimum possible degree of conjugation was found to have important advantages for addressing solid cancer indications in vivo. The development of this technology for both therapeutic and diagnostics applications will be carried out by Syndivia in Strasbourg, France.<\/p>\n<p><a href=\"https:\/\/www.syndivia.com\/\">www.syndivia.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<\/div>\n\t\t<\/div><\/div><div id=\"pgc-17833-2-1\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-2-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"4\" ><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"39\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-150x39.png\" class=\"image wp-image-17813  attachment-thumbnail size-thumbnail\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-150x39.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-300x79.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-500x131.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-600x157.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-200x52.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo.png 630w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/div><\/div><\/div><div id=\"pg-17833-3\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-17833-3-0\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-3-0-0\" class=\"so-panel widget widget_text panel-first-child panel-last-child\" data-index=\"5\" >\t\t\t<div class=\"textwidget\"><p><em><strong>Signia Therapeutics, startup boost\u00e9e par PULSALYS, repositionne des m\u00e9dicaments pour de nouvelles ,indications antimicrobiennes.<\/strong>\u00a0(PULSALYS)<\/em><\/p>\n<p>Issue d\u2019un programme de recherche de 10 ans men\u00e9 par le Dr. Manuel Rosa-Calatrava et son \u00e9quipe au sein du Laboratoire de Virologie et Pathologie Humaine rattach\u00e9 au CIRI (UCBL, ENS Lyon, Inserm et CNRS) avec le soutien fort des filiales de l\u2019UCBL, Lyon Ing\u00e9nierie Projet (LIP) et EZUS, puis boost\u00e9e par PULSALYS, la startup Signia Therapeutics fond\u00e9e en avril 2017 propose une technologie de rupture qui permet de repositionner des m\u00e9dicaments d\u00e9j\u00e0 sur le march\u00e9 pour de nouvelles indications th\u00e9rapeutiques anti-infectieuses. Laur\u00e9ate du concours i-Lab 2017 et labellis\u00e9e \u00ab French Tech Seed \u00bb par le consortium Pouss@LYS en mars dernier, Signia a finalis\u00e9 une premi\u00e8re lev\u00e9e de fonds qui lui permettra de poursuivre le d\u00e9veloppement de sa plateforme SIGNATURA de criblage in silico, d\u2019\u00e9valuation et de validation in vitro, ex vivo et in vivo de m\u00e9dicaments pour leur repositionnement dans le traitement des infections respiratoires.<\/p>\n<p><a href=\"https:\/\/signiatherapeutics.com\/fr\/\">signiatherapeutics.com<\/a><\/p>\n<p>\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2014\u2013<\/p>\n<\/div>\n\t\t<\/div><\/div><div id=\"pgc-17833-3-1\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-3-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"6\" ><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"77\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Signia-Therapeutics-150x77.png\" class=\"image wp-image-17815  attachment-thumbnail size-thumbnail\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Signia-Therapeutics-150x77.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Signia-Therapeutics-196x100.png 196w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/Logo-Signia-Therapeutics.png 200w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/div><\/div><\/div><div id=\"pg-17833-4\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-17833-4-0\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-4-0-0\" class=\"so-panel widget widget_text panel-first-child panel-last-child\" data-index=\"7\" >\t\t\t<div class=\"textwidget\"><p><em><strong>Syndivia in-licenses novel antibody against tumor-specific form of CD146 from SATT Sud-Est.<\/strong>\u00a0(Conectus)<\/em><\/p>\n<p>Syndivia, a biotechnology company focused on the development of new therapeutic modalities for solid cancers based on specific targeting of the tumor microenvironment and anatomical hallmarks, announced today that it has been granted an exclusive, worldwide sublicense by SATT Sud-Est to the immunoconjugates of the anti-CD146-ts antibody (excluding diagnosis), which binds a tumor-specific form of CD146 found on a number of solid cancers. CD146-ts has a central role in the mechanism of tumorigenesis and has the potential to address a current unmet need in cancer therapy. The development of novel biologic entities (NBE) targeting CD146-ts will be undertaken by Syndivia in Strasbourg, France.<\/p>\n<p><a href=\"https:\/\/www.syndivia.com\/\">www.syndivia.com<\/a><\/p>\n<\/div>\n\t\t<\/div><\/div><div id=\"pgc-17833-4-1\"  class=\"panel-grid-cell\" ><div id=\"panel-17833-4-1-0\" class=\"so-panel widget widget_media_image panel-first-child panel-last-child\" data-index=\"8\" ><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"39\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-150x39.png\" class=\"image wp-image-17813  attachment-thumbnail size-thumbnail\" alt=\"\" style=\"max-width: 100%; height: auto;\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-150x39.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-300x79.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-500x131.png 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-600x157.png 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo-200x52.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/02\/sdv_logo.png 630w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Retrouvez les derni\u00e8res actualit\u00e9s des start-up accompagn\u00e9es par les SATT. Depuis leur cr\u00e9ation, les SATT ont contribu\u00e9 \u00e0 la cr\u00e9ation de 418 start-up Deep Tech #SATTUP ! NewClin, une clinique virtuelle pour accompagner le grand public dans une d\u00e9marche de sant\u00e9 personnalis\u00e9e.\u00a0(PULSALYS) Incub\u00e9e par PULSALYS, la startup NewClin d\u00e9veloppe une plateforme digitale gratuite d\u2019e-sant\u00e9 bas\u00e9e [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":11835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[562],"tags":[],"class_list":["post-17833","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-satt-network"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020 - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"headline\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020\",\"datePublished\":\"2020-02-05T08:37:02+00:00\",\"dateModified\":\"2020-02-05T13:08:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/\"},\"wordCount\":619,\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"articleSection\":[\"SATT Network\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/\",\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020 - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"datePublished\":\"2020-02-05T08:37:02+00:00\",\"dateModified\":\"2020-02-05T13:08:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"contentUrl\":\"https:\\\/\\\/www.satt.fr\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Sattup.png\",\"width\":6399,\"height\":3569},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/satt-up-janvier-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/#\\\/schema\\\/person\\\/6f20a7d0bc03146f6e34a9f08d941fec\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/www.satt.fr\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020 - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/"},"author":{"name":"admin","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"headline":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020","datePublished":"2020-02-05T08:37:02+00:00","dateModified":"2020-02-05T13:08:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/"},"wordCount":619,"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","articleSection":["SATT Network"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/","url":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/","name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020 - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","datePublished":"2020-02-05T08:37:02+00:00","dateModified":"2020-02-05T13:08:49+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2018\/12\/Sattup.png","width":6399,"height":3569},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/satt-up-janvier-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"SATT-UP ! L\u2019actualit\u00e9 des start-up accompagn\u00e9es par les SATT #14 \u2013 Janvier 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/6f20a7d0bc03146f6e34a9f08d941fec","name":"admin","url":"https:\/\/www.satt.fr\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/17833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=17833"}],"version-history":[{"count":2,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/17833\/revisions"}],"predecessor-version":[{"id":17835,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/17833\/revisions\/17835"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/11835"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=17833"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=17833"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=17833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}